Press "Enter" to skip to content

New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR)

0
Copyright © DrugPatentWatch. Originally published at New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR)

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29
Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29

Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

Drug patent litigation for XYOSTED (AUTOINJECTOR).

This drug has forty-seven patent family members in thirteen countries.

The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. One supplier is listed for this compound. Additional details are available on the testosterone enanthate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR)
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions